RJFSA
BIOL

Raymond James Financial Services Advisors’s Biolase, Inc. BIOL Stock Holding History

Raymond James Financial Services Advisors’s Portfolio BIOL Stock Details BIOL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-4
Closed -$3K – 3106
2020
Q3 		$3K Hold
4
– – ﹤0.01% 2867
2020
Q2 		$5K Hold
4
– – ﹤0.01% 2804
2020
Q1 		$4K Hold
4
– – ﹤0.01% 2412
2019
Q4 		$6K Hold
4
– – ﹤0.01% 2835
2019
Q3 		$11K Buy
+4
New +$13.2K ﹤0.01% 2774
2017
Q4 		– Sell
-1
Closed -$9K – 2727
2017
Q3 		$9K Hold
1
– – ﹤0.01% 2548
2017
Q2 		$15K Buy
+1
New +$14.8K ﹤0.01% 2490

Other funds holding BIOL

OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
WPC
White Pine Capital Bloomington, Minnesota $355M AUM 45.63% 1-Year Est. Return

Raymond James Financial Services Advisors's BIOL Position: Q4 2020 in Review

Raymond James Financial Services Advisors sold out of Biolase, Inc. (BIOL) in Q4 2020, closing a stake of 4 shares — an estimated $3K sold.

Raymond James Financial Services Advisors first reported a position in BIOL in Q2 2017 and held it in 7 quarters. The position peaked at $15K in Q2 2017. 29 funds tracked by Wall St. Rank hold BIOL as of Q4 2020.

  • Raymond James Financial Services Advisors reported no remaining Biolase, Inc. position as of Q4 2020 after selling out during the quarter.
  • Raymond James Financial Services Advisors sold 4 Biolase, Inc. shares in Q4 2020, an estimated $3K.
  • Raymond James Financial Services Advisors first reported a position in Biolase, Inc. in Q2 2017 and held it in 7 quarters.
  • Raymond James Financial Services Advisors's Biolase, Inc. position peaked at $15K in Q2 2017.
  • 29 funds tracked by Wall St. Rank held Biolase, Inc. as of Q4 2020.

Based on Raymond James Financial Services Advisors's 13F filing for Q4 2020, filed 12 Feb 2021.